| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/31/2001 | CN1061375C Using allogeneic promoter to express transparent Tremellineae haemoglobin in streptomycete |
| 01/31/2001 | CN1061374C Synthetic DNA series of coded sweet protein and production method thereof |
| 01/31/2001 | CN1061373C Method for preparing monomer insulin |
| 01/30/2001 | US6180850 Ku70 is the noncatalytic subunit of dna-protein kinase, encoded by specified polynucleotides; transgenic plants; modulating the level of ku70 in a plant; modulating nucleic acid expression in plants |
| 01/30/2001 | US6180849 Trangenic mice with a disruption in the tiar gene |
| 01/30/2001 | US6180784 Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein |
| 01/30/2001 | US6180778 Process for the separation of double-stranded/single-stranded nucleic acid structures |
| 01/30/2001 | US6180776 MTS2 gene |
| 01/30/2001 | US6180774 Synthetic DNA sequences having enhanced expression in monocotyledonous plants and method for preparation thereof |
| 01/30/2001 | US6180773 The cc type chemokines belong to a family of polypeptides which have proven to be mediators of immune reactions, and which have antiviral activity with respect to hiv |
| 01/30/2001 | US6180772 Nucleic acids encoding dominant negative I-κ-B -α polypeptides |
| 01/30/2001 | US6180771 Given nucleotide sequence; useful for pharmaceutical administration or methods of diagnosing sensitivity to house dust mites |
| 01/30/2001 | US6180769 Method for linking negatively charged macrobiomolecules to plastics, resulting linked compositions and microtitre plates incorporating same |
| 01/30/2001 | US6180766 Nucleosides and oligonucleotides containing boron clusters |
| 01/30/2001 | US6180760 Of given amino acid sequence, a cdna sequence, and antibody specifically recognizing 1-afadin; 1-afadin contributes to the cell-to-cell adherens junction (aj) having a role in individual formation of animals and pathigenesis |
| 01/30/2001 | US6180614 Methods of immunization of aquaculture species by introducing dna expression systems into the aquaculture species |
| 01/30/2001 | US6180613 AAV-mediated delivery of DNA to cells of the nervous system |
| 01/30/2001 | US6180604 Compositions and methods for treating infections using analogues of indolicidin |
| 01/30/2001 | US6180408 Detecting target site on template nucleic acid by chain extension and termination using fluorescently labeled dideoxynucleotide, then detecting polarization of fluorophore; sensitive, automatic diagnosis and genotyping |
| 01/30/2001 | US6180407 Cloning and/or sequencing vector |
| 01/30/2001 | US6180406 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 01/30/2001 | US6180403 Antisense inhibition of tumor necrosis factor alpha converting enzyme (TACE) expression |
| 01/30/2001 | US6180399 Synthetic rna having endonuclease activity and altered substrate binding site; for multifunctional enzyme |
| 01/30/2001 | US6180391 Vector for cloning preferential heterologous nucleotide sequences |
| 01/30/2001 | US6180388 Process for the enzymatic hydrolysis of polyamide 6.6 to give adipic acid monomers and hexamethylenediamine monomers |
| 01/30/2001 | US6180387 Nucleotide sequence coding an enzymatic polypeptide; for the detection of bactericides and batericidal agonist and antagonists which prevent bacterial infection |
| 01/30/2001 | US6180386 DNA sequences coding for the human proteins Tx and Ty related to the interleukin-1beta converting enzyme |
| 01/30/2001 | US6180385 Nucleotide sequences coding a viral enzymatic polypeptide; for the detection of modulators of proteolytic activity |
| 01/30/2001 | US6180384 Compounds |
| 01/30/2001 | US6180383 Insect proteolytic enzyme; for the prevention of insect infestation |
| 01/30/2001 | US6180382 Xylanase derived from a bacillus species, expression vectors for such xylanase and other proteins, host organisms therefor and use thereof |
| 01/30/2001 | US6180380 Cloning of a new member of the serine threonine kinase family |
| 01/30/2001 | US6180379 Eukaryotic transport protein; for utilization in the ubiquination and degradation of cell cycle polypeptides |
| 01/30/2001 | US6180377 Humanized antibodies |
| 01/30/2001 | US6180373 Eschericha and cornyebacteria which are genetically engineered to produce amplified concentratons of preferential amino acids |
| 01/30/2001 | US6180371 Modified factor VIII |
| 01/30/2001 | US6180370 Preparing preferential antibodies; generating nucleotide sequences coding preferential antibodies, expressing nucleotide sequences in transformed cell and recovering preferential antibodies |
| 01/30/2001 | US6180369 Varicella-zoster virus antigen |
| 01/30/2001 | US6180368 Ryegrass pollen allergen |
| 01/30/2001 | US6180367 Recovering heterologous proteins from microorganisms; culture transformed microorganismal cells with expression vector, incubate with inducer, propagate, lyse cells and recover accumulated heterologous protein |
| 01/30/2001 | US6180366 Methods for producing heterologous polypeptides in trichothecene-deficient |
| 01/30/2001 | US6180364 Protein called epil/placentin, process for the preparation of this protein and pharmaceutical composition containing such, DNA coding for said protein |
| 01/30/2001 | US6180363 Recoding of DNA sequences permitting expression in yeast and obtained transformed yeast |
| 01/30/2001 | US6180362 Peptides which inhibit ras protein activity, their preparation and use |
| 01/30/2001 | US6180361 Recombinant DNA expression vectors and DNA compounds that encode deacetoxycephalosporin C synthetase and deacetylcephalosporin C synthetase |
| 01/30/2001 | US6180360 Process of producing β-lactam antibiotics applying micro-organisms with increased ligase activity |
| 01/30/2001 | US6180359 Industrial scale process for the preparation of 2-hydroxy-4-methylbutyric acid using a nitrilase |
| 01/30/2001 | US6180358 Detecting modulators of kinase activity; incubate modulator with cells expressing kinase polypeptide, detect modulation of kinase activity |
| 01/30/2001 | US6180353 Nucleotide sequences associated with suppression of transcription binding protein associated with apoptosis; for the treatment and prevention defects associated with apoptosis |
| 01/30/2001 | US6180346 Electropolymerizable film, and method of making and use thereof |
| 01/30/2001 | US6180343 Green fluorescent protein fusions with random peptides |
| 01/30/2001 | US6180341 In vitro scanning saturation mutagenesis of proteins |
| 01/30/2001 | US6180339 Nucleic acid probes for the detection and identification of fungi |
| 01/30/2001 | US6180338 Amplification of preferential nucleotide sequences; hybridizing separate oligonucleotides to target sequences, ligate oligonucleotides, separate ligation product, hybridize to oligonucleotide, amplify and detect polymorphism |
| 01/30/2001 | US6180337 Diagnosis of the fragile X syndrome |
| 01/30/2001 | US6180336 Labelling and selection of molecules |
| 01/30/2001 | US6180334 Artificial recombinant substrate (rAGG 1) and native aggrecan to determine the proteolytic activity of ‘aggrecanase’ in cell culture systems |
| 01/30/2001 | US6180333 Classification of tumors; obtaining tumor tissue, evaluating preferential protein amounts, comparing to control levels, classifying tumor pathology |
| 01/30/2001 | US6180112 Pasteurella haemolytica vaccine |
| 01/30/2001 | US6180111 Vaccine delivery system |
| 01/30/2001 | US6180110 Attenuated hepatitis a virus vaccine which grows in MRC-5 cells |
| 01/30/2001 | US6180109 Nucleotide and polypeptide sequences of pestivirus strains |
| 01/30/2001 | US6180108 For enhancing integration of expression vectors into the genomic dna in host mammalian cell lines |
| 01/30/2001 | US6180104 Can be used such as nucleotide probes, combining with foreign dna sequences to produce novel t-cell receptors, which can be used in an analogous manner as antibodies, or constructs can be provided which provide for extrachromosomal elements |
| 01/30/2001 | US6180098 Recombinant helicoverpa baculoviruses expressing heterologous DNA |
| 01/30/2001 | CA2313825A1 Myostatin regulatory region, nucleotide sequence determination and methods for its use |
| 01/30/2001 | CA2177604C Labelling of nucleic acid analogue-peptide chimerae |
| 01/30/2001 | CA2069337C Dna, constructs, cells and plants derived therefrom |
| 01/30/2001 | CA2064558C Method for inhibiting growth of stem cells |
| 01/30/2001 | CA2056997C A human cytokine, interleukin-9 |
| 01/30/2001 | CA2022610C Human gp130 protein |
| 01/30/2001 | CA2017067C Herbicide resistant maize |
| 01/30/2001 | CA1341174C Procoagulant proteins derived from factor viii: c |
| 01/27/2001 | CA2314447A1 Graphical viewer for biomolecular sequence data |
| 01/27/2001 | CA2312626A1 A recombinant newcastle disease virus as an embryo vaccine |
| 01/25/2001 | WO2001006573A1 Photodetector |
| 01/25/2001 | WO2001006262A1 Diagnostics and therapeutics for macular degeneration |
| 01/25/2001 | WO2001006018A1 Antisense modulation of map kinase kinase 6 expression |
| 01/25/2001 | WO2001006017A2 Methods for preparing quantities of preselected polynucleotide sequences and uses thereof |
| 01/25/2001 | WO2001006016A2 Amplification of nucleic acids with electronic detection |
| 01/25/2001 | WO2001006015A1 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 01/25/2001 | WO2001006013A1 Methods for determining the specificity and sensitivity of oligonucleotides for hybridization |
| 01/25/2001 | WO2001006010A1 Antisense modulation of telomeric repeat binding factor 1 expression |
| 01/25/2001 | WO2001006009A1 Restriction site profiling |
| 01/25/2001 | WO2001006008A2 Multiplexed strand displacement for nucleic acid determinations |
| 01/25/2001 | WO2001006007A2 Method for the identification of a receptor |
| 01/25/2001 | WO2001006006A1 Environmental stress resistance gene |
| 01/25/2001 | WO2001006005A2 Diagnostic method comprising wt1 sequences |
| 01/25/2001 | WO2001006004A2 A method for amplifying low abundance nucleic acid sequences and means for performing said method |
| 01/25/2001 | WO2001005999A1 Assay member and method for its manufacture |
| 01/25/2001 | WO2001005996A1 Process for producing optically active pyridineethanol derivatives |
| 01/25/2001 | WO2001005994A2 Method for introducing a substance into a cell |
| 01/25/2001 | WO2001005993A1 Cellular absorption of dna |
| 01/25/2001 | WO2001005992A1 Virus vectors and preparations and their uses |
| 01/25/2001 | WO2001005991A1 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 01/25/2001 | WO2001005990A1 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 01/25/2001 | WO2001005989A1 Method of constructing recombinant adenovirus vector |
| 01/25/2001 | WO2001005988A1 Live recombinant vaccine against avian leukosis virus using a marek's disease virus (mdv) virus as vector |
| 01/25/2001 | WO2001005987A1 Trap vector and gene trapping method by using the same |
| 01/25/2001 | WO2001005986A2 Mites-like element and transcriptional activation element |